American Asset Management’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-314
Closed -$232K 101
2017
Q3
$232K Sell
314
-23
-7% -$19.1K 0.14% 78
2017
Q2
$293K Sell
337
-6
-2% -$5.03K 0.16% 56
2017
Q1
$291K Buy
343
+11
+3% +$9.11K 0.18% 53
2016
Q4
$253K Buy
332
+3
+0.9% +$2.27K 0.28% 57
2016
Q3
$270K Buy
+329
New +$284K 0.15% 50

Other funds holding AGN.PRA

American Asset Management's AGN.PRA Position: Q4 2017 in Review

American Asset Management sold out of Allergan plc (AGN.PRA) in Q4 2017, closing a stake of 314 shares — an estimated $232K sold.

American Asset Management first reported a position in AGN.PRA in Q3 2016 and held it in 5 quarters. The position peaked at $293K in Q2 2017. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • American Asset Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • American Asset Management sold 314 Allergan plc shares in Q4 2017, an estimated $232K.
  • American Asset Management first reported a position in Allergan plc in Q3 2016 and held it in 5 quarters.
  • American Asset Management's Allergan plc position peaked at $293K in Q2 2017.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on American Asset Management's 13F filing for Q4 2017, filed 17 Jan 2018.